KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Total Current Liabilities (2016 - 2025)

Jazz Pharmaceuticals has reported Total Current Liabilities over the past 16 years, most recently at $2.2 billion for Q4 2025.

  • Quarterly Total Current Liabilities rose 115.92% to $2.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, up 115.92% year-over-year, with the annual reading at $2.2 billion for FY2025, 115.92% up from the prior year.
  • Total Current Liabilities was $2.2 billion for Q4 2025 at Jazz Pharmaceuticals, down from $2.3 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $2.3 billion in Q3 2025 and troughed at $705.4 million in Q2 2022.
  • The 5-year median for Total Current Liabilities is $987.6 million (2023), against an average of $1.2 billion.
  • Biggest five-year swings in Total Current Liabilities: crashed 34.54% in 2024 and later skyrocketed 120.79% in 2025.
  • Tracing JAZZ's Total Current Liabilities over 5 years: stood at $809.3 million in 2021, then grew by 15.31% to $933.2 million in 2022, then surged by 64.67% to $1.5 billion in 2023, then tumbled by 32.42% to $1.0 billion in 2024, then skyrocketed by 115.92% to $2.2 billion in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $2.2 billion, $2.3 billion, and $2.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.